Page last updated: 2024-08-23

ng-nitroarginine methyl ester and Cardiomyopathies

ng-nitroarginine methyl ester has been researched along with Cardiomyopathies in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (9.52)18.2507
2000's13 (61.90)29.6817
2010's5 (23.81)24.3611
2020's1 (4.76)2.80

Authors

AuthorsStudies
Chen, JS; Chen, JW; Huang, PH; Huang, WP; Lin, SJ; Yin, WH1
Chibbar, R; Lane, N; Ndisang, JF1
Biwer, LA; D'Souza, KM; Hale, TM; Madhavpeddi, L; Ramaiah, P; Shahid, W1
Bhimaraj, A; Celis, R; Cordero-Reyes, AM; Estep, JD; Flores-Arredondo, JH; Hamilton, DJ; Orrego, CM; Torre-Amione, G; Trevino, AR; Youker, KA1
Akita, Y; Iwasaka, T; Matsuhisa, S; Moriguchi, A; Okazaki, T; Otani, H; Sato, D; Yamashita, K1
Kasal, DA; Mandarim-de-Lacerda, CA; Neves, MF; Oigman, W1
Amour, J; Birenbaum, A; Heymes, C; Loyer, X; Michelet, P; Riou, B1
Braun-Dullaeus, RC; Ebner, B; Forkmann, M; Heerwagen, C; Kasper, M; Marquetant, R; Schmeisser, A; Schober, K; Schoen, S; Strasser, RH; Wunderlich, C1
Czabanka, M; Eklund, L; Heljasvaara, R; Ilves, M; Janmey, P; Kerkelä, R; Leskinen, H; Peuhkurinen, K; Pihlajaniemi, T; Piuhola, J; Rasi, K; Ruskoaho, H; Rysä, J; Sormunen, R; Vajkoczy, P; Vuolteenaho, O1
Filho, CS; Grings, M; Knebel, LA; Leipnitz, G; Moura, AP; Tonin, AM; Wajner, M; Zanatta, A1
Draper, NJ; El-Omar, MM; Lord, R; Shah, AM1
Heydemann, A; Huber, JM; Kakkar, R; McNally, EM; Wheeler, MT1
Ahmadi, SH; Borhani, AA; Dehpour, AR; Ebrahimi, F; Hajrasouliha, AR; Houshmand, G; Riazi, K; Sadeghipour, H; Shafaroodi, H; Tavakoli, S1
Coelho, OR; De Luca, IM; Ferreira-Melo, SE; Hyslop, S; Irigoyen, MC; Moreno, H; Tanus-Santos, JE; Yugar-Toledo, JC1
Kukreja, RC1
Mayhan, WG; Rubinstein, I1
Donahue, JK; Kikkawa, K; Lawrence, JH; Marban, E; Thomas, AD1
Mandarim-de-Lacerda, CA; Pessanh, MG1
Adler, GK; Kifor, I; Ochoa-Maya, MR; Rennke, HG; Rocha, R; Stier, CT; Williams, GH1
Hintze, TH; Loke, KE; Messina, EJ; Mital, S1
Cittadino, M; Coelho, OR; Coelho-Filho, OR; De Luca, IM; Hyslop, S; Moreno Júnior, H; Sampaio, RC; Tanus-Santos, JE1

Other Studies

21 other study(ies) available for ng-nitroarginine methyl ester and Cardiomyopathies

ArticleYear
Fenofibrate attenuates doxorubicin-induced cardiac dysfunction in mice via activating the eNOS/EPC pathway.
    Scientific reports, 2021, 01-13, Volume: 11, Issue:1

    Topics: Animals; Cardiomyopathies; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Endothelial Progenitor Cells; Endothelium; Fenofibrate; Heart Failure; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-akt; Signal Transduction; Vascular Endothelial Growth Factor A

2021
Heme oxygenase suppresses markers of heart failure and ameliorates cardiomyopathy in L-NAME-induced hypertension.
    European journal of pharmacology, 2014, Jul-05, Volume: 734

    Topics: Adiponectin; Aldosterone; Animals; Antioxidants; Arginine; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Cardiomyopathies; Cardiotonic Agents; Chemokine CCL2; Chemokine CCL3; Cyclic GMP; Dinoprost; Endothelin-1; Enzyme Induction; Extracellular Matrix Proteins; Heart Failure; Heme; Heme Oxygenase (Decyclizing); Hypertension; Interleukin-1beta; Interleukin-6; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Tyrosine

2014
Persistent change in cardiac fibroblast physiology after transient ACE inhibition.
    American journal of physiology. Heart and circulatory physiology, 2015, Volume: 309, Issue:8

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomyopathies; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Collagen Type I; Disease Models, Animal; Enalapril; Fibroblasts; Fibrosis; Granulocyte-Macrophage Colony-Stimulating Factor; Heart Ventricles; Hypertension; Inflammation Mediators; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phenotype; Rats, Inbred SHR; Time Factors

2015
Full Expression of Cardiomyopathy Is Partly Dependent on B-Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis.
    Journal of the American Heart Association, 2016, Jan-14, Volume: 5, Issue:1

    Topics: Angiotensin II; Animals; Apoptosis; B-Lymphocytes; Cardiomyopathies; Collagen; Cytokines; Disease Models, Animal; Fibroblasts; Fibrosis; Genetic Predisposition to Disease; Heart Failure; Hypertrophy, Left Ventricular; Immunoglobulin G; Magnetic Resonance Imaging; Male; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, SCID; Myocardium; NG-Nitroarginine Methyl Ester; Phenotype; Sialic Acid Binding Ig-like Lectin 2; Signal Transduction; Sodium Chloride; Stroke Volume; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling

2016
N-acetylcysteine abolishes the protective effect of losartan against left ventricular remodeling in cardiomyopathy hamster.
    Antioxidants & redox signaling, 2008, Volume: 10, Issue:12

    Topics: Acetylcysteine; Amidines; Angiotensin II Type 1 Receptor Blockers; Animals; Benzylamines; Cardiomyopathies; Cricetinae; Drug Interactions; Enzyme Inhibitors; Fibrosis; Free Radical Scavengers; Heart; Heart Ventricles; Losartan; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Organ Size; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Ventricular Function, Left; Ventricular Remodeling

2008
Allopurinol attenuates L-NAME induced cardiomyopathy comparable to blockade of angiotensin receptor.
    Histology and histopathology, 2008, Volume: 23, Issue:10

    Topics: Allopurinol; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomyopathies; Disease Models, Animal; Enzyme Inhibitors; Hypertension; Imidazoles; Male; Myocardium; NG-Nitroarginine Methyl Ester; Olmesartan Medoxomil; Rats; Rats, Wistar; Tetrazoles; Time Factors; Uric Acid; Ventricular Remodeling; Xanthine Oxidase

2008
Preservation of the positive lusitropic effect of beta-adrenoceptors stimulation in diabetic cardiomyopathy.
    Anesthesia and analgesia, 2008, Volume: 107, Issue:4

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiomyopathies; Colforsin; Diabetes Complications; Diabetes Mellitus, Experimental; Echocardiography; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Papillary Muscles; Phentolamine; Pindolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta

2008
Nitric oxide synthases are crucially involved in the development of the severe cardiomyopathy of caveolin-1 knockout mice.
    Biochemical and biophysical research communications, 2008, Dec-19, Volume: 377, Issue:3

    Topics: Animals; Cardiomyopathies; Caveolin 1; Enzyme Inhibitors; Fibrosis; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Physical Conditioning, Animal; Superoxides

2008
Collagen XV is necessary for modeling of the extracellular matrix and its deficiency predisposes to cardiomyopathy.
    Circulation research, 2010, Nov-12, Volume: 107, Issue:10

    Topics: Age Factors; Aging; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomyopathies; Collagen; Coronary Circulation; Disease Models, Animal; Echocardiography; Elasticity; Enzyme Inhibitors; Extracellular Matrix; Female; Gene Expression Profiling; Gene Expression Regulation; Genotype; Heart Ventricles; Hemodynamics; Hypertension; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Microscopy, Electron; Microscopy, Video; Myocardium; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phenotype; Polymerase Chain Reaction; RNA, Messenger; Telemetry; Ventricular Remodeling

2010
Phytanic acid disturbs mitochondrial homeostasis in heart of young rats: a possible pathomechanism of cardiomyopathy in Refsum disease.
    Molecular and cellular biochemistry, 2012, Volume: 366, Issue:1-2

    Topics: Animals; Antioxidants; Cardiomyopathies; Chromans; Electron Transport Chain Complex Proteins; Glutathione; Homeostasis; In Vitro Techniques; Male; Membrane Potential, Mitochondrial; Mitochondria, Heart; Myocardium; NADP; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxidation-Reduction; Oxidative Stress; Phytanic Acid; Protein Carbonylation; Rats; Rats, Wistar; Refsum Disease; Thiobarbituric Acid Reactive Substances

2012
Role of nitric oxide in posthypoxic contractile dysfunction of diabetic cardiomyopathy.
    European journal of heart failure, 2003, Volume: 5, Issue:3

    Topics: Animals; Cardiomyopathies; Coronary Circulation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Enzyme Inhibitors; Female; Glycated Hemoglobin; Heart Rate; Heart Ventricles; Male; Models, Cardiovascular; Myocardial Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxygen; Rats; Rats, Wistar; Severity of Illness Index; Streptozocin; Stroke Volume; Ventricular Function, Left; Ventricular Pressure

2003
Functional nitric oxide synthase mislocalization in cardiomyopathy.
    Journal of molecular and cellular cardiology, 2004, Volume: 36, Issue:2

    Topics: Adrenergic Agonists; Analysis of Variance; Animals; Carbachol; Cardiomyopathies; Cytoskeletal Proteins; Dystrophin; Heart; Membrane Glycoproteins; Mice; Mice, Knockout; Microsomes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Sarcoglycans; Telomere

2004
Contribution of endogenous opioids and nitric oxide to papillary muscle contractile impairment in cholestatic rats.
    European journal of pharmacology, 2005, Oct-31, Volume: 523, Issue:1-3

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Analysis of Variance; Animals; Bile Ducts; Cardiomyopathies; Cholestasis; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Isoproterenol; Ligation; Male; Myocardial Contraction; Naltrexone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Opioid Peptides; Papillary Muscles; Phenylephrine; Rats; Rats, Sprague-Dawley

2005
Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats.
    European journal of pharmacology, 2006, Aug-07, Volume: 542, Issue:1-3

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Pressure; Cardiomyopathies; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Enzyme Inhibitors; Heart; Hypertension; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phosphodiesterase Inhibitors; Piperazines; Purines; Rats; Rats, Wistar; Sildenafil Citrate; Sulfones

2006
Cardiovascular protection with sildenafil following chronic inhibition of nitric oxide synthase.
    British journal of pharmacology, 2007, Volume: 150, Issue:5

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Antihypertensive Agents; Carbolines; Cardiomyopathies; Cardiovascular Agents; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Doxorubicin; Endothelium, Vascular; Enzyme Inhibitors; Erectile Dysfunction; Heart Failure; Humans; Hypertension; Hypertension, Pulmonary; Imidazoles; Male; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents; Ventricular Remodeling

2007
L-arginine dilates cheek pouch arterioles in hamsters with hereditary cardiomyopathy but not in controls.
    The Journal of laboratory and clinical medicine, 1995, Volume: 125, Issue:3

    Topics: Animals; Arginine; Arterioles; Cardiomyopathies; Cheek; Cricetinae; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Reference Values; Vasodilation

1995
Acceleration of widespread adenoviral gene transfer to intact rabbit hearts by coronary perfusion with low calcium and serotonin.
    Gene therapy, 1998, Volume: 5, Issue:5

    Topics: Adenoviridae; Animals; Bradykinin; Calcium; Cardiomyopathies; Coronary Circulation; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Heart; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Perfusion; Permeability; Rabbits; Serotonin; Time Factors

1998
Myofibroblast accumulation in healing rat myocardium due to long-term low-dosage nitric oxide synthesis inhibition.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2000, Volume: 52, Issue:3

    Topics: Animals; Cardiomyopathies; Collagen; Enzyme Inhibitors; Female; Fibroblasts; Fibronectins; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar

2000
Aldosterone: a mediator of myocardial necrosis and renal arteriopathy.
    Endocrinology, 2000, Volume: 141, Issue:10

    Topics: Adrenalectomy; Aldosterone; Angiotensin II; Animals; Blood Pressure; Cardiomyopathies; Enzyme Inhibitors; Eplerenone; Hormone Antagonists; Kidney; Male; Myocardium; Necrosis; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Renal Artery; Renin; Sodium Chloride; Spironolactone; Vascular Diseases

2000
Impaired nitric oxide modulation of myocardial oxygen consumption in genetically cardiomyopathic hamsters.
    Journal of molecular and cellular cardiology, 2000, Volume: 32, Issue:12

    Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Bradykinin; Cardiomyopathies; Cricetinae; Dose-Response Relationship, Drug; Echocardiography; Enzyme Inhibitors; Kinins; Male; Mesocricetus; Muscles; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Organ Size; Oxygen; Oxygen Consumption; Penicillamine; Ramipril; Vasodilator Agents

2000
Pravastatin reduces myocardial lesions induced by acute inhibition of nitric oxide biosynthesis in normocholesterolemic rats.
    International journal of cardiology, 2001, Volume: 79, Issue:2-3

    Topics: Analysis of Variance; Animals; Anticholesteremic Agents; Cardiomyopathies; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Necrosis; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase; Nitrites; Pravastatin; Rats; Rats, Wistar; Thromboxane B2

2001